Literature DB >> 8886424

Analogues of diverse structure are unable to differentiate native melatonin receptors in the chicken retina, sheep pars tuberalis and Xenopus melanophores.

H Pickering1, S Sword, S Vonhoff, R Jones, D Sugden.   

Abstract

1. The pineal hormone melatonin exerts its biological effects through specific, high affinity G-protein coupled receptors. Recently, three melatonin receptor subtypes (Mel1a, Mel1b and Mel1c) have been cloned. Neither the cloned subtypes, nor the native receptors have yet been compared in a detailed pharmacological analysis. 2. The present study examined the structure-activity relationships of a series of 21 melatonin analogues, by comparing their potency on the pigment aggregation response in Xenopus laevis melanophores with their affinity in radioligand binding competition studies in chicken retina and sheep pars tuberalis (PT), two tissues in which melatonin is known to mediate a biological response. 3. All but four of the analogues were full melatonin receptor agonists producing a concentration-related redistribution of pigment granules in cultured Xenopus melanophores. The remaining analogues produced little pigment aggregation at 10 microM. 4. Saturation studies with 2-[125I]-iodomelatonin identified a single binding site in the chicken retina and sheep PT membranes, with a KD of 36.6 +/- 2.8 and 37.3 +/- 4.3 pM, and a maximal number of binding sites (Bmax) of 16.6 +/- 0.5, and 40.1 +/- 1.7 fmol mg-1 protein, respectively. 5. Comparison of the potency/affinity of the analogues for the binding sites gave a highly significant correlation in each case, retina/melanophore, r = 0.97 (P < 0.001, n = 17), PT/melanophore, r = 0.97 (P < 0.001, n = 17) and PT/retina, r = 0.98 (P < 0.001, n = 21). 6. Despite their large range in affinity and structural diversity these melatonin agonists were unable to distinguish between melatonin receptors in the chicken retina, sheep pars tuberalis and Xenopus melanophores.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886424      PMCID: PMC1915861          DOI: 10.1111/j.1476-5381.1996.tb15997.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Structure-activity relationships of melatonin and related indoleamines.

Authors:  C B Heward; M E Hadley
Journal:  Life Sci       Date:  1975-10-10       Impact factor: 5.037

2.  The action of melatonin on single amphibian pigment cells in tissue culture.

Authors:  E A Messenger; A E Warner
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides.

Authors:  P J Garratt; S Travard; S Vonhoff; A Tsotinis; D Sugden
Journal:  J Med Chem       Date:  1996-04-26       Impact factor: 7.446

5.  Free-running activity rhythms in the rat: entrainment by melatonin.

Authors:  J Redman; S Armstrong; K T Ng
Journal:  Science       Date:  1983-03-04       Impact factor: 47.728

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  N-Acetyltryptamine antagonizes the melatonin-induced inhibition of [3H]dopamine release from retina.

Authors:  M L Dubocovich
Journal:  Eur J Pharmacol       Date:  1984-10-01       Impact factor: 4.432

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Radioligand binding affinity and biological activity of the enantiomers of a chiral melatonin analogue.

Authors:  D Sugden; D J Davies; P J Garratt; R Jones; S Vonhoff
Journal:  Eur J Pharmacol       Date:  1995-12-20       Impact factor: 4.432

10.  Characterization of a retinal melatonin receptor.

Authors:  M L Dubocovich
Journal:  J Pharmacol Exp Ther       Date:  1985-08       Impact factor: 4.030

View more
  2 in total

1.  The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores.

Authors:  M T Teh; D Sugden
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).

Authors:  Célia Gautier; Sophie-Penelope Guenin; Isabelle Riest-Fery; Tahlia Jade Perry; Céline Legros; Olivier Nosjean; Valerie Simonneaux; Frank Grützner; Jean A Boutin
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.